Vanessa Trump reveals breast cancer diagnosis and treatment plan
Vanessa Trump announced she has been diagnosed with breast cancer, is working with her medical team on a treatment plan, and asked for privacy as she focuses on her health.
Tag
Breast Cancer
All articles tagged with #breast cancer
Vanessa Trump opens up about breast cancer diagnosis and treatment plan
Vanessa Trump announced she has been diagnosed with breast cancer, underwent a procedure this week, and is working with her medical team on a treatment plan, asking for privacy while receiving strong family support.
Vanessa Trump Announces Breast Cancer Diagnosis at 48
Vanessa Trump, the former daughter-in-law of President Donald Trump, revealed on Instagram that she has been diagnosed with breast cancer and is working with her medical team on a treatment plan, asking for privacy while she focuses on health and recovery.
Kylie Minogue Reveals Hidden Second Breast Cancer Diagnosis During Comeback
Kylie Minogue says in a new documentary that she was diagnosed with a second breast cancer in early 2021, more than 15 years after her first battle, a secret she kept during her career resurgence highlighted by the 2023 hit Padam Padam. She emphasizes that the diagnosis was detected early and urges others not to skip screenings as she continues her comeback.
Kylie Minogue says cancer experience still with me, guiding future plans
Kylie Minogue says her breast cancer diagnosis remains with her today, a theme she discusses in a new three‑part Netflix documentary. She reflects on the emotional shock of her diagnosis, the humiliation of early hostile media coverage, and the pressures of fame and social media, while hinting at a possible Hyde Park return and continuing acting and music.
Mammogram timing diverges as experts push toward personalized screening
Guidelines on when to start and how often to screen with mammograms clash among major groups, reflecting imperfect risk prediction. ACP recommends average-risk women 50–74 get mammograms every two years, with 40–49 discussing pros/cons; USPSTF starts at 40 every two years; ACS favors yearly screening for 45–54 (start at 40 optional) and allows switching after 55. Dense breasts and emerging tools like 3D mammography, broader genetic risk tests, and AI risk models may tailor later practice, but experts say regular screening remains most beneficial when a shared plan is followed with a clinician.
Underarm Aluminum in Antiperspirants: Plausible Risk, No Proven Breast‑Cancer Link
The piece reviews concerns that aluminum salts used in antiperspirants—often near breast tissue—could influence breast cancer risk. While some lab studies suggest weak estrogen-like activity and a few breast-tissue detections exist, major reviews find no clear causal link and note the evidence is limited and inconsistent. Scientists call for better long-term prospective studies, and readers are given practical options: check labels for aluminum salts, consider aluminum-free deodorants, patch-test new products, and discuss personal risk with clinicians. Marketing terms like “natural” are not standardized, and the decision to switch should balance personal comfort, skin sensitivity, and potential risk.
NBC New York’s Sara Gore reveals breast cancer diagnosis, taking leave for treatment
NBC New York host Sara Gore announced she has breast cancer and will step away from her shows for treatment and surgery. She spoke candidly about the emotional impact, noting a family history of the disease, but expressed gratitude for the support of doctors, colleagues, and viewers and plans to return after treatment.
NBC Host Sara Gore Announces Breast Cancer, Plans a Courageous Return
NBC 4 lifestyle host Sara Gore revealed she has breast cancer and will take leave for treatment and surgery. She described the diagnosis as emotionally challenging and said she’s grateful for excellent medical care, vowing to return stronger and to see viewers on the other side of treatment.
NBC's Sara Gore Reveals Breast Cancer Diagnosis On-Air, Plans Treatment Leave
NBC host Sara Gore revealed on the Thursday episode of New York Live that she has been diagnosed with breast cancer and will take a leave of absence to pursue treatment and surgery, saying she was caught off guard but grateful for support and optimistic about returning better than ever.
NBC New York's Sara Gore Reveals Breast Cancer Diagnosis, Takes Leave for Treatment
NBC New York host Sara Gore announced she has breast cancer and will pause her work for treatment and surgery, expressing fear but gratitude for support and a hopeful plan to return stronger.
Sara Gore Goes On-Air With Breast Cancer Diagnosis, Plans Treatment Pause
NBC New York host Sara Gore revealed on-air that she has been diagnosed with breast cancer and will take a leave of absence for treatment and surgery, citing high family risk and an emotional impact, while thanking her support system and vowing to return stronger after healing.
AstraZeneca stock slides after FDA advisory panel rejects camizestrant
An FDA advisory panel voted 6-3 against approving AstraZeneca's oral breast cancer drug camizestrant due to concerns about trial design, sending AstraZeneca shares about 2% lower in London. While the panel did not question the drug's safety, it said the SERENA-6 results did not prove that early switching to camizestrant improves long-term survival. The company will continue working with the FDA as it reviews the application, and analysts say the setback may be more sentiment-related than a fundamental issue for the stock.
FDA panel rebuffs AstraZeneca's early ESR1-driven camizestrant approach in breast cancer
An FDA advisory panel voted 6-3 against approving AstraZeneca's oral SERD camizestrant for HR-positive, HER2-negative metastatic breast cancer with ESR1 mutations detected before progression, citing insufficient evidence of a meaningful long-term benefit and trial-design concerns (no crossover, OS data immature). Approval now seems unlikely despite a progression-free survival improvement seen in Serena-6.
New Map of Aging Breast Tissue Reveals Why Cancer Risk Increases with Age
A study analyzing normal breast tissue from 527 women (over 3 million cells) created a detailed map of how breast tissue changes with age, finding dramatic remodeling around menopause—shrinking milk-producing lobules, fewer epithelial and immune cells, increased fat, and a shift to a tissue environment that can better support cancer development. Younger breasts had more cancer-fighting B- and T-cells, while older breast tissue showed fewer of these cells and more pro-cancer immune cells like M2 macrophages, helping explain why breast cancer risk rises with age. The work, published in Nature Aging, underscores how aging tissue and immune landscape contribute to cancer susceptibility.